Literature DB >> 30239074

Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task.

Christina S Meade1,2,3, Ryan P Bell1, Sheri L Towe1, Nan-Kuei Chen3,4, Andrea L Hobkirk1, Scott A Huettel2,3,5.   

Abstract

Marijuana use, which is disproportionately prevalent among human immunodeficiency virus (HIV)-infected persons, can alter activity in fronto-parietal regions during cognitively demanding tasks. While HIV is also associated with altered neural activation, it is not known how marijuana may further affect brain function in this population. Our study examined the independent and additive effects of HIV infection and regular marijuana use on neural activation during a cognitive interference task. The sample included 93 adults who differed on marijuana (MJ) and HIV statuses (20 MJ+/HIV+, 19 MJ+/HIV-, 29 MJ-/HIV+, 25 MJ-/HIV-). Participants completed a counting Stroop task during a functional magnetic resonance imaging scan. Main and interactive effects on neural activation during interference versus neutral blocks were examined using a mixed-effects analysis. The sample showed the expected Stroop effect for both speed and accuracy. There were main effects of MJ in the right and left inferior parietal lobules, with the left cluster extending into the posterior middle temporal gyrus and a main effect of HIV in the dorsal anterior cingulate cortex. There was an interaction in the left fronto-insular cortex, such that the MJ+/HIV+ group had the largest increase in activation compared with other groups. Among MJ+, signal change in this cluster correlated positively with cumulative years of regular marijuana use. These results suggest that comorbid HIV and marijuana use is associated with complex neural alterations in multiple brain regions during cognitive interference. Follow-up research is needed to determine how marijuana-related characteristics may moderate HIV neurologic disease and impact real-world functioning.
© 2018 Society for the Study of Addiction.

Entities:  

Keywords:  HIV; Stroop; cannabis; functional magnetic resonance imaging (fMRI); inhibitory control; marijuana

Year:  2018        PMID: 30239074      PMCID: PMC6713620          DOI: 10.1111/adb.12678

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  53 in total

1.  Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning.

Authors:  Jordan E Cattie; Katie Doyle; Erica Weber; Igor Grant; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2012-06-25       Impact factor: 2.475

Review 2.  Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review.

Authors:  Samantha J Broyd; Hendrika H van Hell; Camilla Beale; Murat Yücel; Nadia Solowij
Journal:  Biol Psychiatry       Date:  2015-12-08       Impact factor: 13.382

3.  Marijuana use and viral suppression in persons receiving medical care for HIV-infection.

Authors:  Chukwuemeka N Okafor; Zhi Zhou; Larry E Burrell; Natalie E Kelso; Nicole E Whitehead; Jeffery S Harman; Christa L Cook; Robert L Cook
Journal:  Am J Drug Alcohol Abuse       Date:  2016-07-11       Impact factor: 3.829

4.  Cocaine dependence modulates the effect of HIV infection on brain activation during intertemporal decision making.

Authors:  Christina S Meade; Andrea L Hobkirk; Sheri L Towe; Nan-Kuei Chen; Ryan P Bell; Scott A Huettel
Journal:  Drug Alcohol Depend       Date:  2017-07-08       Impact factor: 4.492

5.  Meta-analysis of Go/No-go tasks demonstrating that fMRI activation associated with response inhibition is task-dependent.

Authors:  Daniel J Simmonds; James J Pekar; Stewart H Mostofsky
Journal:  Neuropsychologia       Date:  2007-07-28       Impact factor: 3.139

6.  Rostro-caudal and dorso-ventral gradients in medial and lateral prefrontal cortex during cognitive control of affective and cognitive interference.

Authors:  Christoffer Rahm; Benny Liberg; Maria Wiberg-Kristoffersen; Peter Aspelin; Mussie Msghina
Journal:  Scand J Psychol       Date:  2013-01-15

7.  Cocaine and HIV are independently associated with neural activation in response to gain and loss valuation during economic risky choice.

Authors:  Christina S Meade; Merideth Addicott; Andrea L Hobkirk; Sheri L Towe; Nan-Kuei Chen; Sriramkumar Sridharan; Scott A Huettel
Journal:  Addict Biol       Date:  2017-07-06       Impact factor: 4.280

8.  Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version.

Authors:  Marc A Norman; David J Moore; Michael Taylor; Donald Franklin; Lucette Cysique; Chris Ake; Deborah Lazarretto; Florin Vaida; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2011-06-24       Impact factor: 2.475

Review 9.  Pathogenesis of HIV in the central nervous system.

Authors:  Victor Valcour; Pasiri Sithinamsuwan; Scott Letendre; Beau Ances
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

10.  HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.

Authors:  Robert K Heaton; Donald R Franklin; Ronald J Ellis; J Allen McCutchan; Scott L Letendre; Shannon Leblanc; Stephanie H Corkran; Nichole A Duarte; David B Clifford; Steven P Woods; Ann C Collier; Christina M Marra; Susan Morgello; Monica Rivera Mindt; Michael J Taylor; Thomas D Marcotte; J Hampton Atkinson; Tanya Wolfson; Benjamin B Gelman; Justin C McArthur; David M Simpson; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Terry L Jernigan; Joseph Wong; Igor Grant
Journal:  J Neurovirol       Date:  2010-12-21       Impact factor: 2.643

View more
  8 in total

Review 1.  Neuroimaging the Neuropathogenesis of HIV.

Authors:  Anna H Boerwinkle; Karin L Meeker; Patrick Luckett; Beau M Ances
Journal:  Curr HIV/AIDS Rep       Date:  2021-02-25       Impact factor: 5.071

Review 2.  Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function.

Authors:  Sheri L Towe; Christina S Meade; Christine C Cloak; Ryan P Bell; Julian Baptiste; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-22       Impact factor: 4.147

3.  Brain multimodal co-alterations related to delay discounting: a multimodal MRI fusion analysis in persons with and without cocaine use disorder.

Authors:  Christina S Meade; Xiang Li; Sheri L Towe; Ryan P Bell; Vince D Calhoun; Jing Sui
Journal:  BMC Neurosci       Date:  2021-08-20       Impact factor: 3.288

4.  Machine learning prediction of neurocognitive impairment among people with HIV using clinical and multimodal magnetic resonance imaging data.

Authors:  Yunan Xu; Yizi Lin; Ryan P Bell; Sheri L Towe; John M Pearson; Tauseef Nadeem; Cliburn Chan; Christina S Meade
Journal:  J Neurovirol       Date:  2021-01-19       Impact factor: 2.643

5.  Synergistic effects of HIV and marijuana use on functional brain network organization.

Authors:  Shana A Hall; Zahra Lalee; Ryan P Bell; Sheri L Towe; Christina S Meade
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-07-18       Impact factor: 5.067

6.  Cannabis use impacts pre-stimulus neural activity in the visual cortices of people with HIV.

Authors:  Nicholas J Christopher-Hayes; Brandon J Lew; Alex I Wiesman; Mikki Schantell; Jennifer O'Neill; Pamela E May; Susan Swindells; Tony W Wilson
Journal:  Hum Brain Mapp       Date:  2021-08-31       Impact factor: 5.038

7.  HIV infection is linked with reduced error-related default mode network suppression and poorer medication management abilities.

Authors:  Jessica S Flannery; Michael C Riedel; Taylor Salo; Ranjita Poudel; Angela R Laird; Raul Gonzalez; Matthew T Sutherland
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-07-03       Impact factor: 5.067

8.  Microstructural brain abnormalities in HIV+ individuals with or without chronic marijuana use.

Authors:  Hannah A Wang; Hua-Jun Liang; Thomas M Ernst; Kenichi Oishi; Linda Chang
Journal:  J Neuroinflammation       Date:  2020-08-06       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.